Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 4 , Pages 241-249 , August 2007

Growth factors and plasticity

  • Stéphane V. Sizonenko

      Affiliations

    • Service du Développement et de la Croissance, Département de Pédiatrie, Faculté de Médecine, Geneva, Switzerland
    • ,
  • Nathalie Bednarek

      Affiliations

    • Inserm, U676, Paris, France
    • Institut Alix de Champagne, Unité de Réanimation Infantile et de Médecine Néonatale, Reims, France
    • ,
  • Pierre Gressens

      Affiliations

    • Inserm, U676, Paris, France
    • Université Paris 7, Faculté de Médecine Denis Diderot, IFR02 and IFR25, Paris, France
    • Corresponding Author InformationCorresponding author. Inserm U676, Hôpital Robert Debré, 48 Blvd Sérurier, F-75019 Paris, France. Tel.: +33 0 1 4003 1976; fax: +33 0 1 4003 1995.

References 

  1. Huppi PS. Advances in postnatal neuroimaging: relevance to pathogenesis and treatment of brain injury. Clin Perinatol. 2002;29:827–856
  2. Shankaran S. The postnatal management of the asphyxiated term infant. Clin Perinatol. 2002;29:675–692
  3. Nakajima W, Ishida A, Lange MS, Gabrielson KL, Wilson MA, Martin LJ, et al. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci. 2000;20:1994–2004
  4. Feldman DE, Brecht M. Map plasticity in somatosensory cortex. Science. 2005;310:810–815
  5. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004;22:123–131
  6. Beilharz EJ, Klempt ND, Klempt M, Sirimanne E, Dragunow M, Gluckman PD. Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res. 1993;18:209–215
  7. Ward Platt M, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med. 2005;10:341–350
  8. Tsai PJ, Yu CH, Hsu SP, Lee YH, Chiou CH, Hsu YW, et al. Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity. Clin Endocrinol (Oxf). 2004;61:88–93
  9. Letterio JJ, Geiser AG, Kulkarni AB, Roche NS, Sporn MB, Roberts AB. Maternal rescue of transforming growth factor-beta 1 null mice. Science. 1994;264:1936–1938
  10. Spong CY, Lee SJ, McCune SK, Gibney G, Abebe DT, Alvero R, et al. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology. 1999;140:917–924
  11. Rice JE, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol. 1981;9:131–141
  12. Williams CE, Gunn AJ, Synek B, Gluckman PD. Delayed seizures occurring with hypoxic-ischemic encephalopathy in the fetal sheep. Pediatr Res. 1990;27:561–565
  13. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 1995;54:358–370
  14. Guan J, Williams CE, Gunning MI, Mallard CE, Gluckman PD. The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. J Cereb. Blood Flow Metab. 1993;13:611–616
  15. Brywe KG, Mallard C, Gustavsson M, Hedtjarn M, Leverin AL, Wang X, et al. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?. Eur J Neurosci. 2005;21:1489–1502
  16. Johnston BM, Mallard CE, Williams CE, Gluckman PD. Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lamb. J Clin Invest. 1996;97:300–308
  17. Tagami M, Ikeda K, Nara Y, Fujino H, Kubota A, Numano F, et al. Insulin-like growth factor-1 attenuates apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Lab Invest. 1997;76:613–617
  18. Guan J, Bennet L, George S, Waldvogel HJ, Faull RLM, Gluckman PD, et al. Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep. Neuroscience. 2000;95:831–839
  19. Yamamoto H, Murphy LJ. Generation of des-(1–3) insulin-like growth factor-i in serum by an acid protease. Endocrinology. 1994;135:2432–2439
  20. Gillespie C, Read LC, Bagley CJ, Ballard FJ. Enhanced potency of truncated insulin-like growth factor-I (des(1–3)IGF- I) relative to IGF-1 in lit/lit mice. J Endocrinol. 1990;127:401–405
  21. Carlsson-Skwirut C, Jörnvall H, Holmgren A, Andersson C, Bergman T, Lundquist G, et al. Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Letters. 1986;201:46–50
  22. Guan J, Waldvogel HJ, Faull RLM, Gluckman PD, Williams CE. The effects of the N-terminal tripeptide of insulin-like growth factor-1, Glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. Neuroscience. 1999;89:649–659
  23. Sizonenko SV, Sirimanne ES, Williams CE, Gluckman PD. Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury. Brain Res. 2001;922:42–50
  24. Guan J, Svedin P, Mathai S, Zhang R, Hagberg H, et al. Peripheral administration of GPE analogue reduces brain injury in immature brain possibly due to protection of astrocytes, neovascularization and depressing IL-6. Dev Neurosci, in press.
  25. Lin S, Fan LW, Pang Y, Rhodes PG, Mitchell HJ, Cai Z. IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 2005;1063:15–26
  26. Guan J, Bennet L, George S, Wu D, Waldvogel HJ, Gluckman PD, et al. Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab. 2001;21:493–502
  27. Ness JK, Wood TL. Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis. Mol Cell Neurosci. 2002;20:476–488
  28. Ness JK, Scaduto RC, Wood TL. IGF-1 prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors. Glia. 2004;46:183–194
  29. Holtzman DM, Sheldon RA, Jaffe W, Cheng Y, Ferriero DM. Nerve growth factor protects the neonatal brain against hypoxic–ischemic injury. Ann Neurol. 1996;39:114–122
  30. Han BH, D'Costa A, Back SA, Parsadanian M, Patel S, Shah AR, et al. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol Dis. 2000;7:38–53
  31. Husson I, Rangon CM, Lelievre V, Bemelmans AP, Sachs P, Mallet J, et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex. 2005;15:250–261
  32. Markham A, Cameron I, Franklin P, Spedding M. BDNF increases rat brain mitochondrial respiratory coupling at complex I, but not complex II. Eur J Neurosci. 2004;20:1189–1196
  33. Mesples B, Fontaine RH, Lelievre V, Launay JM, Gressens P. Neuronal TGF-beta1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol Dis. 2005;18:193–205
  34. Dicou E, Attoub S, Gressens P. Neuroprotective effects of leptin in vivo and in vitro. Neuroreport. 2001;12:3947–3951
  35. Gressens P, Marret S, Martin JL, Laquerriere A, Lombet A, Evrard P. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades: in vivo and in vitro studies. J Neurochem. 1998;70:2574–2584
  36. Husson I, Mesples B, Bac P, Vamecq J, Evrard P, Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol. 2002;51:82–92
  37. Gressens P, Besse L, Robberecht P, Gozes I, Fridkin M, Evrard P. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. J Pharmacol Exp Ther. 1999;288:1207–1213
  38. Sara VR, Carlson-Skwirut C, Drakenberg K, Giacobini MB, Hakanson L, Mirmrian M, et al. The Biological role of truncated insulin-like growth factor-1 and tripeptide GPE in the central nervous system. An New York Acad Sciences. 1993;692:183–191
  39. Kuroiwa T, Ueki M, Chen Q, Ichinose S, Okeda R. Is the swelling in brain edema isotropic or anisotropic?. Acta Neurochir Suppl (Wien). 1994;60:155–157
  40. Batchelor DC, Lin H, Wen JY, Keven C, Van Zijl PL, Breier BH, et al. Pharmacokinetics of glycine-proline-glutamate, the N-terminal tripeptide of insulin-like growth factor-1, in rats. Anal Biochem. 2003;323:156–163
  41. Guan J, Thomas GB, Lin H, Mathai S, Bachelor DC, George S, et al. Neuroprotective effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate (GPE) following intravenous infusion in hypoxic-ischemic adult rats. Neuropharmacology. 2004;47:892–903
  42. Bemelmans AP, Husson I, Jaquet M, Mallet J, Kosofsky BE, Gressens P. Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. J Neurosci Res. 2006;83:50–60
  43. Dicou E, Rangon CM, Guimiot F, Spedding M, Gressens P. Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brain. Brain Res. 2003;970:221–225
  44. Nawarskas J, Rajan V, Frishman WH. Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Heart Dis. 2001;3:378–385
  45. Schwartz JC. Racecadotril: a new approach to the treatment of diarrhoea. Int J Antimicrob Agents. 2000;14:75–79
  46. Medja F, Lelievre V, Fontaine RH, Lebas F, Leroux P, Ouimet T, et al. Thiorphan, a neutral endopeptidase inhibitor used for diarrhea, is neuroprotective in newborn mice. Brain. 2006;129:3209–3223
  47. Welin AK, Svedin P, Lapatto R, Sultan B, Hagberg H, Gressens P, et al. Melatonin reduces inflammation and cell death in white matter in the 0.65 gestation fetal sheep following umbilical cord occlusion. Pediatr Res. 2006;61:153–158
  48. Penev PD, Zee PC. Melatonin: a clinical perspective. Ann Neurol. 1997;42:545–553
  49. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, et al. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001;50:756–760
  50. Teasell R, Bitensky J, Foley N, Bayona NA. Training and stimulation in post stroke recovery brain reorganization. Top Stroke Rehabil. 2005;12:37–45
  51. The important references are indicated with asterisks

PII: S1744-165X(07)00008-X

doi: 10.1016/j.siny.2007.01.007

Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 4 , Pages 241-249 , August 2007

Article Tools

* Image Usage & Resolution